
3.68 Delayed Data As of May 20 | ![]() Today’s Change | 2.49 Today|||52-Week Range 5.53 | -15.79% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $929.4M |
MannKind Corp. 1 Casper Street Danbury Connecticut 06810 |
Michael E. Castagna | Chief Executive Officer & Director |
Steven B. Binder | Chief Financial & Accounting Officer |
Joseph Kocinsky | Chief Technology Officer |
Kevin Kaiserman | Vice President-Medical Affairs & Safety |
Thomas Hofmann | Chief Scientific Officer |